MYRIAD GENETICS - Dusseldorf Stock Exchang (MYD DU) stock market data APIs
€4.6404
0(0%)
as of July 4, 2025
Try our APIs with
free plan!
MYRIAD GENETICS - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MYD.DU.
Prev. Close
4.6404
Open
4.6404
High
4.6912
Low
4.625
52 wk Range
3.38-26.2
Market Cap
1 751 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MYRIAD GENETICS - Dusseldorf Stock Exchang data using free add-ons & libraries
Get MYRIAD GENETICS - Dusseldorf Stock Exchang Fundamental Data
MYRIAD GENETICS - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get MYRIAD GENETICS - Dusseldorf Stock Exchang Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get MYRIAD GENETICS - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MYRIAD GENETICS - Dusseldorf Stock Exchang News
New
5 Revealing Analyst Questions From Myriad Genetics’s Q1 Earnings Call
Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset in fu...
Should You Hold Myriad Genetics Stock in Your Portfolio Right Now?
Myriad Genetics, Inc. MYGN focuses on the expansion of companion diagnostics, market expansion through new clinical guidelines and providing new offerings in its Oncology business. The company plans t...
3 Hyped Up Stocks Skating on Thin Ice
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, o...
3 Reasons to Avoid MYGN and 1 Stock to Buy Instead
What a brutal six months it’s been for Myriad Genetics. The stock has dropped 67.5% and now trades at $4.91, rattling many shareholders. This was partly due to its softer quarterly results and may h...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
